Cargando…

The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis

BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmud, Sultan, Mohsin, Md, Hossain, Sorif, Islam, Md Mynul, Muyeed, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499991/
https://www.ncbi.nlm.nih.gov/pubmed/36168558
http://dx.doi.org/10.1016/j.heliyon.2022.e10728
_version_ 1784795118635581440
author Mahmud, Sultan
Mohsin, Md
Hossain, Sorif
Islam, Md Mynul
Muyeed, Abdul
author_facet Mahmud, Sultan
Mohsin, Md
Hossain, Sorif
Islam, Md Mynul
Muyeed, Abdul
author_sort Mahmud, Sultan
collection PubMed
description BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study aims to inspect the COVID-19 vaccine acceptance rate worldwide and the regional variation of the acceptance rates among the general population and healthcare workers across different territories of the world. In addition, it compares the vaccine acceptance rates between the pre- and post-vaccine approval periods. METHOD: A comprehensive systematic review was conducted using PRISMA statements. After quality evaluation, the data from eligible studies were analyzed using the random effect model. Q-test and [Formula: see text] statistics were used to search for heterogeneity. The publication bias was assessed by using Egger’s test and funnel plot. RESULTS: The combined COVID-19 vaccine acceptance rate among the general population and healthcare workers (n = 1,581,562) was estimated at 62.79% (95% CI: 58.98–66.60). The acceptance rate substantially decreased from 66.29% (95% CI: 61.24–71.35) to 56.69% (95% CI: 48.68–64.71) among the general population from the pre-to post-vaccine approval periods but remained almost constant at 58.25% (95% CI: 46.52–69.97) among healthcare workers. The acceptance rates also varied in different regions of the world. The highest acceptance rate was found in the South-East Asia region at 70.18% (95% CI: 58.12–82.25) and the lowest was found in African Region at 39.51% (95% CI: 23.42–55.59). CONCLUSION: Low COVID-19 vaccine acceptance rate might be a massive barrier to controlling the pandemic. More research is needed to address the responsible factors influencing the low global rate of COVID-19 vaccine acceptance. Integrated global efforts are required to remove the barriers.
format Online
Article
Text
id pubmed-9499991
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94999912022-09-23 The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis Mahmud, Sultan Mohsin, Md Hossain, Sorif Islam, Md Mynul Muyeed, Abdul Heliyon Research Article BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study aims to inspect the COVID-19 vaccine acceptance rate worldwide and the regional variation of the acceptance rates among the general population and healthcare workers across different territories of the world. In addition, it compares the vaccine acceptance rates between the pre- and post-vaccine approval periods. METHOD: A comprehensive systematic review was conducted using PRISMA statements. After quality evaluation, the data from eligible studies were analyzed using the random effect model. Q-test and [Formula: see text] statistics were used to search for heterogeneity. The publication bias was assessed by using Egger’s test and funnel plot. RESULTS: The combined COVID-19 vaccine acceptance rate among the general population and healthcare workers (n = 1,581,562) was estimated at 62.79% (95% CI: 58.98–66.60). The acceptance rate substantially decreased from 66.29% (95% CI: 61.24–71.35) to 56.69% (95% CI: 48.68–64.71) among the general population from the pre-to post-vaccine approval periods but remained almost constant at 58.25% (95% CI: 46.52–69.97) among healthcare workers. The acceptance rates also varied in different regions of the world. The highest acceptance rate was found in the South-East Asia region at 70.18% (95% CI: 58.12–82.25) and the lowest was found in African Region at 39.51% (95% CI: 23.42–55.59). CONCLUSION: Low COVID-19 vaccine acceptance rate might be a massive barrier to controlling the pandemic. More research is needed to address the responsible factors influencing the low global rate of COVID-19 vaccine acceptance. Integrated global efforts are required to remove the barriers. Elsevier 2022-09-23 /pmc/articles/PMC9499991/ /pubmed/36168558 http://dx.doi.org/10.1016/j.heliyon.2022.e10728 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Mahmud, Sultan
Mohsin, Md
Hossain, Sorif
Islam, Md Mynul
Muyeed, Abdul
The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title_full The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title_fullStr The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title_full_unstemmed The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title_short The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
title_sort acceptance of covid-19 vaccine at early stage of development and approval: a global systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499991/
https://www.ncbi.nlm.nih.gov/pubmed/36168558
http://dx.doi.org/10.1016/j.heliyon.2022.e10728
work_keys_str_mv AT mahmudsultan theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT mohsinmd theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT hossainsorif theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT islammdmynul theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT muyeedabdul theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT mahmudsultan acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT mohsinmd acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT hossainsorif acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT islammdmynul acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis
AT muyeedabdul acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis